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Abstract
Background: There is an increase of serum levels of IgE during Plasmodium falciparum infections in
individuals living in endemic areas. These IgEs either protect against malaria or increase malaria
pathogenesis. To get an insight into the exact role played by IgE in the outcome of P. falciparum infection,
total IgE levels and functional anti-parasite IgE response were studied in children and adults, from two
different endemic areas Gabon and India, exhibiting either uncomplicated malaria, severe non cerebral
malaria or cerebral malaria, in comparison with control individuals.
Methodology and results: Blood samples were collected from controls and P. falciparum-infected
patients before treatment on the day of hospitalization (day 0) in India and, in addition, on days 7 and 30
after treatment in Gabon. Total IgE levels were determined by ELISA and functional P. falciparum-specific
IgE were estimated using a mast cell line RBL-2H3 transfected with a human Fcε RI α-chain that triggers
degranulation upon human IgE cross-linking. Mann Whitney and Kruskall Wallis tests were used to
compare groups and the Spearman test was used for correlations.
Total IgE levels were confirmed to increase upon infection and differ with level of transmission and age
but were not directly related to the disease phenotype. All studied groups exhibited functional parasite-
specific IgEs able to induce mast cell degranulation in vitro in the presence of P. falciparum antigens. Plasma
IgE levels correlated with those of IL-10 in uncomplicated malaria patients from Gabon. In Indian patients,
plasma IFN-γ , TNF and IL-10 levels were significantly correlated with IgE concentrations in all groups.
Conclusion: Circulating levels of total IgE do not appear to correlate with protection or pathology, or
with anti-inflammatory cytokine pattern bias during malaria. On the contrary, the P. falciparum-specific IgE
response seems to contribute to the control of parasites, since functional activity was higher in
asymptomatic and uncomplicated malaria patients than in severe or cerebral malaria groups.
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Malaria is a complex disease that kills between one and
two million people every year. Most of those affected are
children under five years of age, non-immune individuals
and pregnant women [1]. The principal cause of death is
infection by Plasmodium falciparum due to its ability to
induce severe complications such as severe anaemia and/
or cerebral malaria (CM) often associated with hypogly-
caemia [2-4]. The physiopathology of malaria cannot be
represented by a single scheme. For example, patients who
develop CM present a range of acute neurological mani-
festations and the disease is characterized by a diffuse
encephalopathy, altered levels of consciousness, deep
coma and seizure leading to death. Even though during
the last few years a lot of information has become availa-
ble from clinical and experimental studies, the causes of
CM remain to be determined. The clinical outcome of a P.
falciparum infection depends on the genetic factors of the
host and parasite, and also on host immune responses.
Antibodies and T cells are among the immune factors
thought to play a role in mediating protection and also
pathology [2-5].
P. falciparum infection increases the serum levels of IgM
and IgG antibodies but also IgE in individuals living in
endemic areas [6-12]. IgEs may protect against or partici-
pate in malaria pathogenesis. The association of high anti-
P. falciparum IgE levels with a reduced risk of developing
clinical malaria suggests the involvement of IgE in protec-
tion [13,14]. The observation that circulating levels of IgE
most often correlate with severe rather than uncompli-
cated disease suggests a pathogenic role of IgE [8,10-12],
and the positive correlation between the levels of IgE/IgE
immune complexes and the levels of TNF in CM patients
provides supporting evidence [8,10-12]. The exact role
played by IgE in malaria is still unclear.
IgE is an immunoglobulin isotype that only exists in
mammals. It is present at very low concentrations in the
serum of normal individuals, at levels ranging from 10 to
300 ng/ml [9]. Its functional effect has been shown to
depends on Fc receptors expressed on mast cells and
basophils both in mice and humans, as well as on eosi-
nophils, monocytes/macrophages and platelets in
humans [9]. IgEs positively regulate both of their recep-
tors: the high affinity receptor (Fcε RI) and the low affinity
receptor (Fcε RII or CD23) [15]. The Fcε RI is expressed
only on mast cells and/or basophils in both mice and
humans [9,16]. The binding of IgE to the high affinity
receptor on the mast cell membrane and its subsequent
aggregation with antigens results in degranulation and the
release of mediators that further aggravate an ongoing
allergic process [17]. On basophils, the cross-linking of
Fcε RI-bound IgE rapidly induces the release of IL-4 and
IL-13 [16], among other inflammatory mediators. The
low affinity receptor (Fcε RII) is the second major and
widely distributed IgE receptor. It is also known as CD23
and is constitutively expressed on B cells and is induced by
IL-4 on macrophages, some T cells, human eosinophils
and platelets [9,16]. The cross-linking of CD23 on macro-
phages or on other CD23-bearing effector cells by IgE-
containing immune complexes is thought to play a path-
ogenic role in malaria via TNF-mediated pathways [16].
This study aimed to evaluate the total and functional P.
falciparum-specific IgE responses, the association of these
responses with plasma cytokine patterns and the pheno-
type of the disease in endemic controls and infected
patients with different clinical forms of malaria. The
infected patients originated from a low endemic area in
India and a high endemic area in Gabon.
Materials and methods
Study population
Patients from Gabon
All the patients included in this study were children aged
between 0.1 and 6 years (mean age = 2.6 years) recruited
between 1996 and 2000 at the Owendo Pediatric Hospital
(OPH) and the Libreville Hospital Center (LHC) in
Gabon (see Table 1). Informed parental consent had been
obtained. Gabon has an equatorial climate that is hot and
humid, with an endemic malaria transmission. The study
design was approved by the local health office ethics com-
mittee. The patients were distributed into different groups
according to World Health Organization (WHO) guide-
lines for the definition of uncomplicated and severe
malaria [18]. A cohort of 135 P. falciparum-infected chil-
dren was constituted and divided into three groups
according to disease severity [[6], 67] 50patients with
uncomplicated malaria (UM), 29 with severe non-cere-
bral malaria (SM) developing severe anaemia (haemo-
globin level < 5 g/dl), or hypoglycaemia (glycaemia < 2.2
mmol/ml), and 17 with severe cerebral malaria (CM)
with a Blantyre Coma Score < 2, or three convulsive epi-
sodes during 24 hours before admission with post-critical
comatose > 15 minutes]. Two control groups were
recruited: an uninfected group, also called endemic con-
trol (EC) group, comprising 17 children with P. falci-
parum-negative thin blood smear, and asymptomatic
infected group (AI) comprising 22 children with no clini-
cal manifestation of malaria but a P. falciparum-positive
thin blood smear.
Patients from India
Malaria patients were recruited in the village of Gondia,
an endemic region in the north-east of the Maharashtra
State of India. The village is surrounded by forest. Gondia
has been known as an endemic area for at least the last 20
years. P. falciparum appeared in Gondia over the last 10
years. It is transmitted during the rainy season in June,Page 2 of 13
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January) and becomes rare as summer approaches
(March, April and May). The studied groups consisted of
98 patients from four to 72 years of age, being predomi-
nantly adults (see Table 1). Six cohorts were constituted
according to WHO criteria for uncomplicated and severe
malaria: two control groups of uninfected individuals
from non-endemic (NEC) and endemic regions (EC)
comprising nine and 14 patients respectively; three groups
of infected patients, with 31 developing uncomplicated
malaria (UM), 13 developing severe non-cerebral malaria
(SM) and 26 developing cerebral malaria (CM); and one
group of five patients that had recovered from CM (ex-cer-
ebral malaria patients, Ex-CM). Between eight and 10% of
the CM malaria cases died. UM cases were treated as out-
patients. SM patients were admitted to hospital fully con-
scious and could respond well verbally to doctors'
questions. CM cases were in coma. Drug treatment was
paracetamol, quinine and arteether (E-mal®). Samples
were collected after obtaining the consent of the patients,
or of their families. Blood samples from endemic controls
were collected from the relatives of malaria patients
(brothers/sisters/parents) with their consent. These con-
trols had not suffered from malaria during the previous
two years. Non-endemic blood samples were collected
from individuals who had not suffered from malaria dur-
ing the previous five years.
Blood sample collection and parasite assessment
Venous blood was collected on EDTA in sterile vacutain-
ers from each patient on the day of hospitalization (day 0,
before any treatment), and seven (day 7) and thirty days
later (day 30). Plasma was obtained by centrifuging the
blood samples at 5000 rpm for 15 min. Plasma samples
were stored at -80°C until use.
Parasitaemia was assessed by counting asexual forms of P.
falciparum on thin blood smears under a light microscope
after Giemsa staining. Parasitaemia was expressed as the
mean percentage of infected red blood cells.
Culture of malaria parasites
Erythrocytic stages of the P. falciparum malaria parasite
line FAN 5HS (source: NCCS, Pune, India) and 3D7 were
cultured using candle jar dessicators as previously
described [19]. The culture medium was RPMI 1640
(Gibco-BRL), supplemented with 0.5% AlbuMix (Gibco
BRL). The cultures were maintained in six-well or 24-well
tissue culture plates (NUNC). Parasitaemia was 5% at the
start of culture and reached 25% after six days. Culture
medium and fresh RBCs were added every other day.
Preparation of parasite extracts
Parasite soluble antigen was prepared from synchronous
cultures containing more than 20% mature trophozoites;
more than 6% rings and more than 5% schizonts were
used. The cultures were pooled and centrifuged at 3,000
rpm at 4°C, and the pRBC pellet was kept and the super-
natant discarded. The pRBC pellet was suspended in 10
ml sterile PBS 1 × (0.15 M, pH7.2) and then centrifuged.
The parasitized red blood cell (pRBC) pellet was washed
five times and then lysed by adding 15 ml of 0.1%
saponin. The saponin treatment frees the parasites from
the infected RBCs. This was centrifuged at 6,000 rpm for
30 min at 4°C. The supernatant was discarded and the
parasite pellet was washed five or six times with sterile
Table 1: Characteristics of both studied cohorts: Gabon and India. Clinical group description, according to the number of patients, age, 
sex and parasitaemia.
Clinical Groups Staff Age-mean (min-max) Sex (male-female) Parasitemia (%)
Gabon EC 17 2,7 (0,5–5) 10-7 -
AI 22 2,9 (0,1–5) 12-10 0.22 (0.01–1.2)
UM 50 3 (0,5–5) 22–28 6.88 (0.05–48.6)
SM 29 1,8 (0,2–4,5) 18-11 5.91 (0.08–31)
CM 17 2,4 (0,5–5) 12-5 10.42 (0.15–64)
Total 145 2,6 (0,1–5) 74-61
Índia NEC 9 32,7 (25–63) 8-1 -
EC 14 27,3 (23–37) 13-1 -
UM 31 30,8 (4–70) 18-13 1,24 (0,71–2,18)
SM 13 30,4 (8–65) 10-3 1,11 (0,38–3,21)
CM 26 40,4 (9–72) 16-10 2,04 (1,07–3,87)
ExCM 5 19,36 (7–51) 0–5 -
Total 93 32,3 (4–72) 65-28 1,50 (1,02–2,20)
NEC- non endemic control, EC- endemic control, AI- asymptomatic infected, UM – uncomplicated malaria, SM – severe malaria (non-cerebral), CM 
– cerebral malaria, ExCM – Ex-cerebral malaria. Note: sex couldn't be determined for 1/18, 11/61 and 4/33 patients from EC, UM and SM, 
respectively.Page 3 of 13
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tein isolation buffer containing a cocktail of protease
inhibitors. This was briefly sonicated and the tube was
kept at 4°C for between four and five hours. The contents
of the tube were agitated by cyclo-mixing and then centri-
fuged at 6,000 rpm for 30 min at 4°C. The clean superna-
tant was collected in a separate tube and the pellet was
discarded. The contents were sterilized by passing through
0.22 μm-pore filters. Aliquots of the antigen were frozen
at -70°C until use. Parasite proteins were quantified by
the Bradford method. The concentration of the parasite
line FAN 5HS and 3D7 were 1.2 and 2.6 mg/ml, respec-
tively.
Normal RBC extracts
Normal red blood cell (RBC) extract was prepared from
the same batch of RBCs used for culturing the parasites,
and followed the same procedure as previously described
for pRBCs. Briefly, the RBCs were washed with PBS and
the buffy coat was removed. After centrifugation, the RBC
pellet was suspended in 1 ml protein isolation buffer con-
taining a cocktail of protease inhibitors. This was briefly
sonicated and the tube was kept at 4°C for between four
and five hours. The contents of the tube were agitated by
cyclo-mixing and then centrifuged at 6000 rpm for 30 min
at 4°C. The clean supernatant was collected in a separate
tube and the pellet discarded. The protein contents were
estimated using a protein determination kit (BCATM pro-
tein assay Kit, Pierce, France).
Total IgE levels
An ELISA method was used to detect total IgE plasma lev-
els in samples corresponding to day 0, day 7 and day 30.
ELISA plates (96 microwell plates, reacti-bind 96 EIA Plate
100/PKG, Pierce) were coated with 50 μl/well of purified
sheep polyclonal anti-human IgE solution at 5 μg/ml (The
Binding Site, Birmingham UK) by incubation overnight at
4°C. The plasma samples were diluted 1:5 and incubated
for two hours at 37°C. Bound IgE was detected using a
peroxydase-conjugated polyclonal anti-human-IgE (The
Binding Site, Birmingham UK). Binding was revealed
using the OPD substrate (Sigma) and the product was
quantified from the optical density (OD) at 450 nm.
Serial dilutions ranging from 2 μg/ml to 0.0019 μg/ml of
IgE solution (human monoclonal IgE provided by Dr Thi-
erry Batard – Stallergenes, Anthony, France) gave the
standard curve. The median of each optical density value
was fitted into the sigmoidal standard curve using a spe-
cific ELISA programme running in Igor version 3.16 (Wav-
emetrics, Lake Oswego, OR).
IgE functional assay
A new rat mast cell line RBL-2H3 transfected with a
human Fcε RI α-chain that triggers degranulation upon
human IgE cross-linking was used [20]. Cells were main-
tained in Dulbecco medium (Gibco BRL, Eragny, France)
containing 10% foetal bovine serum (FCS), 100 U/ml
penicillin and 100 U/ml streptomycin (GIBCO BRL,
France). Cells were expanded by incubation at 37°C for
three to four days in complete Dulbecco medium supple-
mented with G418 (GIBCO BRL, France).
β-Hexosaminidase is known as a component of the
basophil and the mast cell specific granule, and is released
during degranulation of these cells [21]. Degranulation
was monitored after antigen stimulation by measuring the
level of released β-hexosaminidase. Fcε RI α-chain RBL-
2H3 transfected rat mast cell line cultures (5 × 105 cells per
well) were incubated with the different serum samples at
a non-cytotoxic dilution (previously determined) for 48
hours at 37°C in the absence of the G418 antibiotic. The
upregulated receptors were saturated by incubation at 4°C
for 30 minutes with the same samples diluted 1:10. The
cells were then washed with PBS 1X, centrifuged and
resuspended in 1 ml Tyrode buffer before being centri-
fuged again. Finally, the cell pellet was resuspended in
450 μl of D2O (50%) and Tyrode buffer (50%) solution
and each culture sample was distributed to 10 ELISA plate
wells. Different controls were carried out for each sample.
Control cells on lane 1 and 2 were subjected to Triton dis-
ruption (Triton 5%) and represented 100% enzyme
release. Cells on lanes 3 and 4 were incubated with 50 μl
of complemented Dulbecco medium without serum and
represented the background enzyme release. Lanes 5 and
6, 7 and 8, 9 and 10 were incubated with 50 μl of different
duplicated concentrations of parasite extract (1,000, 100
and 10 ng/ml) for 30 minutes at 37°C. After centrifuga-
tion of each well sample, 50 μl of each supernatant was
collected and incubated with 50 μl of PNAG substrate
solution for 90 minutes at 37°C. The level of released β-
hexosaminidase was estimated from the OD at 405 nm
using a spectrophotometer. All results are expressed as the
percentage of total β-hexosaminidase in the cells after cor-
recting for spontaneous release in unstimulated cultures,
calculated as following: (experimental β-hexosaminidase
– background β-hexosaminidase)/(total β-hexosamini-
dase – background β-hexosaminidase) × 100.
Flow cytofluorometry analysis
FACS analysis was performed after incubating RBL-2H3-
D12.8 cells with several dilutions of serum samples to fol-
low the induction of the high affinity receptor (Fcε RI)
expression after stimulation by IgEs in the patient's sera.
Cells were incubated for 48 hours at 37°C with the differ-
ent serum samples optimally diluted to avoid cytotoxicity.
A saturation step with the same sera diluted 1:10 was done
by incubation at 4°C for 30 minutes. Cells were washed
with PBS 1X and incubated with FITC-labelled anti-IgE
(Tebu, Le Perray en Yvelines, France) (1/100) for 30 min-
utes. Cells were washed again, centrifuged, resuspended inPage 4 of 13
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software (Beckton Dickinson, USA). 10,000 cells were
acquired per tube.
Cytokine levels
The levels of cytokines in the plasma (IL-4, TNF, INF-γ,
and IL-10) were estimated by Opti-ELISA kits (Pharmin-
gen, San Diego, CA.USA) used following the manufac-
turer's instructions.
Statistics
Due to a non-normal distribution of the scores in each
group, non-parametric tests were performed, using the
median to compare the different clinical groups. The
Mann Whitney test was used for comparisons between
two groups and the Kruskall Wallis test to compare three
or more groups. Spearman's correlation was used to check
for correlations between parameters. P values less than
0.05 were considered as significant. Chi-squared test was
used to compare qualitative variables.
Results
Serum total IgE levels in groups of P. falciparum infected 
patients with different clinical phenotypes
Total IgE levels were analysed in endemic controls and in
cohorts of P. falciparum-infected patients with different
clinical forms of malaria, ranging from asymptomatic to
cerebral disease, from Gabonese and Indian endemic
areas to study the association between the IgE response
and disease severity. Total IgE levels were measured by
ELISA in individual sera before drug administration (cor-
responding to day 0) and determined the general distribu-
tion in the studied populations from Gabon (Figure 1A)
and India (Figure 1B). Total IgE concentrations were
found to be much higher in patients from India (mainly
adults) than in patients from Gabon (children). In both
populations independent of the different levels of IgE in
each population, the median IgE levels within each clini-
cal group tended to increase upon infection (mainly in
UM and SM groups), although the difference between the
groups was only significant in the Indian population
(Kruskall Wallis, p = 0.0005). As only Indian patients
showed a significant difference, the Mann Whitney test
was used to compare the different groups in this popula-
tion only. There was a significant increase in IgE levels in
the EC group compared to the NEC group (p = 0.042). The
most significant increase in IgE levels (versus the EC
group) occurred in the UM patients (p = 0.015) and in the
SM patients (p = 0.013). No significant difference
between the EC group and the CM and Ex-CM groups was
observed.
A range of values of IgE levels was defined enabling the
analysis of the frequency of normal, moderate and high
IgE levels in each clinical group of patients. The so-called
normal values were adjusted to the studied population
because the Gabonese and Indian groups had different
plasma total IgE ranges. Therefore, the normal value (N)
was defined by the median IgE levels in the endemic con-
trols of each study population. Consequently, all values
between N and 2N were considered as low/moderate IgE
levels and those between 2N and 3N as moderate/high IgE
levels, with the highest levels being above 3N (Figures 1C
and 1D). Even in Gabonese patients, for whom the
increase of IgE in the disease groups was not significant, a
higher percentage of patients with clinical disease had
higher IgE levels than controls and asymptomatic
patients. These differences were more marked in the UM,
SM and CM Indian patients (Figure 1D). In the Indian
population, the NEC group did not have moderate/high
IgE levels, although a high percentage of patients exhib-
ited normal IgE levels (Figure 1D). Also, no significant
change was detected in IgE levels over time in the UM, SM
and CM groups of the Gabonese cohorts when tested
seven days and 30 days after treatment (Table 2). No sig-
nificant association of malaria and IgE levels with sex in
the two studied populations. However, a significant
increase in IgE levels with age (p = 0.00034) was observed
in the Gabonese subjects (Figure 2A) but not in the Indian
subjects.
The correlation between IgE levels and the parasite load
was tested. Although the general trend was different in the
Indian and Gabonese population, there was no significant
correlation between IgE concentration and parasite load
for all groups together. In Gabonese cohorts, a negative
correlation for all groups was observed, except for the UM
patients where the correlation showed a positive ten-
dency. In the Indian cohorts, a positive correlation was
observed between IgE levels and parasite load, mainly in
the UM and SM groups (Figure 2B).
Functional parasite specific IgE response in P. falciparum 
infected patients
Previous studies have used ELISA to quantify specific IgE
present in the serum [7,8,10,11]. The functionality of spe-
cific IgEs present in the serum was studied by evaluating
the ability of these IgEs to induce mast cell degranulation
in the presence of the parasite antigen. A rat mast cell line
transfected with the human α-chain of Fcε RI was used
[20]. Human Fcε RI expression was induced after incuba-
tion with all serum samples at non-cytotoxic dilutions.
FACS was used to detect the presence of FcåRI receptors on
the mast cells surface induced by IgE present in serum
samples. Although the fluorescence intensity revealing
human Fcε RI expression by the mast cells varied between
patient samples, IgE receptors were upregulated in all the
samples tested. No correlation between total IgE levels in
the serum and the up-regulation of mast cell receptors was
found. There was no significant correlation between IgEPage 5 of 13
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degranulation. Sensitized cells were then incubated with
different concentrations of a P. falciparum blood-stage
antigen extract. Mast cell degranulation was measured by
quantifying the release of β-hexosaminidase. Control cells
not exposed to any serum gave a maximum mast cell
degranulation of 3%. Therefore, serum samples giving an
enzyme release greater than 5% in the presence of at least
one of the antigen concentrations were considered posi-
tive for functional IgE. In the Gabonese cohorts (Figure
3A), there were functional P. falciparum IgE in all clinical
groups. However, the percentage of patients with func-
tional specific anti-parasite IgE was higher in asympto-
matic and uncomplicated malaria patients than in other
groups. Also, the percentage of patients displaying para-
site-specific IgE was lower in the group exhibiting severe
disease. The distribution of patients per group releasing
between 5 and 10%, 10 and 30% and above 30% β-hex-
osaminidase induced by specific anti-parasite IgE revealed
that one patient in CM group had a degranulation level
above 30%, being the highest induced response among all
the tested individuals. The same assay was carried out on
Distribution of total IgE levels per clinical group in both studied populations: Gabon and IndiaFigure 1
Distribution of total IgE levels per clinical group in both studied populations: Gabon and India. A. Total IgE levels (μg/ml) per 
clinical group in Gabonese patients (non-significant Kruskall Wallis test). B. Total IgE levels (μg/ml) in Indian patients (significant 
Kruskall Wallis test, p = 0.0005). C. Percentage of patients with defined IgE levels per group in the Gabonese population (nor-
mal levels (N) lower than or equal to 0.500 μg/ml, moderate levels (N to 2N), from 0.501 to 1.000 μg/ml, high levels (2N to 
3N), from 1,000 to 1,500 μg/ml, very high (>3N) greater than 1,500 μg/ml). D. Percentage of patients with defined levels of IgE 
per group in the Indian population (normal levels (N) lower than or equal to 4,000 μg/ml, moderate levels (N to 2N), from 
4,000 to 8,000 μg/ml, high levels (2N to 3N), from 8,000 to 12,000 μg/ml, very high (>3N), greater than 12,000 μg/ml). Legend: 
EC – endemic control, AI – Asymptomatic infected, UM – uncomplicated malaria, SM – severe malaria, CM – cerebral malaria, 
NEC – non-endemic control, ExCM – ex-cerebral malaria.Page 6 of 13
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difference between groups, the percentage of patients hav-
ing functional IgE recognizing the parasite extract was
slightly higher in EC and UM groups than in SM and CM
groups (Figure 3B). All positive patients had an enzyme
release of between 10 and 30%. No significant correlation
was found between P. falciparum-specific IgE-induced
mast cell degranulation levels and sex, age and parasitae-
mia.
Relationship between total and specific serum IgE and 
cytokine profiles
IgE production is influenced by cytokines produced by
activated T cells. These cytokines are also involved in
pathophysiological mechanisms associated with severe
malaria [4,22,23]. Therefore, the relationship between the
cytokine profile, the IgE levels and the clinical manifesta-
tion was investigated. IFN-γ, TNF and IL-10 levels were
measured in the sera of the Indian and Gabonese patients.
IL-4 levels were measured only in Indian patients as it was
not different between the Gabonese groups. IFNγ concen-
trations were highest in the Gabonese AI and CM groups
(Table 3). This cytokine is significantly higher in the AI
and CM groups than in EC (p = 0.02 and p = 0.009 respec-
tively). The plasma TNF concentration was similar in the
severe SM and CM groups and in disease-free EC and AI
groups. TNF levels were clearly higher in SM and CM
groups than in the UM group (p < 0.001). Surprisingly, EC
and AI also exhibited higher TNF levels when compared to
UM group. No association between IFN-γ or TNF and IgE
levels were found. However, a significant positive correla-
tion was found between the concentration of total IgE and
IL-10 in the UM group (p = 0.02) and a significant nega-
tive correlation in the AI group (p = 0.02) (Figure 4). The
median levels of the different cytokines in the plasma of
Indian patients are given in Table 4. IL-10 and TNF levels
were higher in CM patients than in controls and other P.
falciparum-infected patients. The plasma concentrations of
these cytokines were moderate in cured CM patients
(ExCM). Their levels of IL-10 and TNF were slightly higher
in endemic controls than in non-endemic controls. Levels
of IFN- were lower in the CM group than in AI group. No
Table 2: Day 0, day 7 and day 30 median IgE levels per clinical group in the Gabonese population.
Total IgE (μg/ml) EC (min-max) AI (min-max) UM (min-max) SM (min-max) CM (min-max)
Day 0 0,525 (0,009–25,47) 0,677 (0–41,96) 0,690 (0,015–13,173) 1,132 (0,016–9,915) 0,922 (0,093–16,34)
Day 7 0,582 (0,0144–5,644) 0,448 (0,0192–3,188) 0,516 (0,011–5,228) 0,836 (0,016–5,689) 8,033 (8,033–8,033)
Day 30 1,026 (0,044–2,628) 0,977 (0,056–7,446) 0,151 (0,052–3,925) 0,662 (0,011–6,315) ------
EC – endemic control, AI – asymptomatic infected, UM – uncomplicated malaria, SM – severe malaria (non-cerebral), CM – cerebral malaria.
A. Total IgE correlation with age in the Gabonese population (significant spearman correlation, p = 1.0 × 10-9)Figure 2
A. Total IgE correlation with age in the Gabonese population (significant spearman correlation, p = 1.0 × 10-9). B. Total IgE 
correlation with parasitaemia in the Indian population. Significant Spearman correlation (p = 0,0001).
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Malaria Journal 2007, 6:1 http://www.malariajournal.com/content/6/1/1difference was found for the levels of IFN-γ between the
uncomplicated and severe disease. Although, there was a
significant correlation between IgE levels and IFN-γ (Fig-
ure 5A), TNF (Figure 5B) and IL-10 (Figure 5C) levels
when looking at all the groups combined. Most diseased
groups had high cytokine levels, whereas control groups
had lower levels (Figure 5A, B and 5C).
Discussion
The main feature of this study is the comparison of total
and functional P. falciparum-specific IgE responses in two
populations of low and high malaria transmission levels,
India and Gabon respectively and their relationship with
disease severity. Several clinical groups were compared:
endemic non-infected controls, asymptomatics and dif-
ferent clinical manifestations including uncomplicated,
severe non-cerebral and cerebral malaria.
Indian and Gabonese individuals exhibited a different
range of plasma levels of circulating IgE These cohorts had
a different age range, with the Gabonese groups being
children from 0 to 6 years of age, whereas Indian patients
had a mean age of 30 years. In the two populations, irre-
spective of its concentration and also consistent with pre-
viously published data, the IgE distribution tended to
increase upon parasite stimulation [8,10,11]. In the
Indian population, circulating IgE levels were seven times
higher in endemic controls than in non-endemic controls.
This suggests that exposure to the parasite strongly influ-
ences the production of IgE, although this difference may
also be due to other endemic factors [7]. Nevertheless, it
was reported that IgE levels were greatest in patients devel-
oping severe disease than in CM group (Figure 1A and
1B). When considering the percentage of patients that
produce high levels of IgE per group, it was shown that IgE
Table 3: Cytokine distribution in the Gabonese population: median TNF, IFN-γ and IL-10 levels per clinical group.
EC (min-max) AI (min-max) UM (min-max) SM (min-max) CM (min-max)
TNF (pg/ml) 41 (8–94) 36 (0–395) 8 (0–440) 175 (1–442) 209 (0–1520)
IFN-γ (pg/ml) 3,2 (0–8) 9,5 (0–31) 5 (0–395) 4 (0–201) 6,2 (2,5–9)
IL-10 (pg/ml) 14 (0–83) 102 (0–317) 134 (0–1380) 339 (0–5200) 95 (0–2300)
EC – endemic control, AI – asymptomatic infected, UM – uncomplicated malaria, SM – severe malaria (non-cerebral), CM – cerebral malaria.
Comparing group by group with the Endemic control: TNF was significantly lower in UM (p = 0,0006); IFN-γ was significantly higher in AI and CM 
(p = 0,02 and p = 0,007, respectively); IL-10 was significantly higher in UM (p = 0,0009), SM (p = 0,0001) and CM (p = 0,0001)
Percentage of patients with positive functional IgE against parasite antigen in the Gabonese and Indian populationsFigure 3
Percentage of patients with positive functional IgE against parasite antigen in the Gabonese and Indian populations. A. Distribu-
tion of patients with positive anti-parasite functional IgE, exhibiting different intensities of enzyme release per clinical group in 
the Gabonese population (low enzyme release, from 5 to 10%; moderate enzyme release, from 10 to 30%; and high enzyme 
release, greater than than 30%). B. Distribution of patients with positive anti-parasite functional IgE in the Indian population.
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Malaria Journal 2007, 6:1 http://www.malariajournal.com/content/6/1/1levels are higher in UM and SM (Figure 1C and 1D) than
in CM patients who had values similar to that of the con-
trols [8,24]. In addition, the median levels of circulating
IgE in the ExCM group were close to that of the CM group.
Also, no significant correlation was found between both
IgE and TNF levels in the CM group. These observations
are contrary to published data describing increased IgE
levels that correlate with high concentrations of circulat-
ing TNF, a cytokine associated with malaria severity and
also with pRBC adherence on brain capillary endothelial
cells [9,10,25,26]. The results suggest that either IgE does
not play an important role in CM pathogenesis, or that
these antibodies may participate in the parasite sequestra-
tion into the brain or other organ capillaries [24].
There was a significant increase in IgE levels with age in
Gabonese children independent of the disease group (Fig-
ure 2). This increase in IgE production between 0 and six
years of age may also reflect an increase in the capacity of
the immune system to respond to parasite infections
[7,27]. Such a correlation was not found in Indian groups.
This would be expected because the Indian groups com-
prised mainly adults, with the few children being older
than five years. Although most of individuals in the
Gabonese endemic control group had already been in
contact with the parasite, as demonstrated by the high
titres of specific antibody to P. falciparum-infected red
blood cells observed in these children, the median plasma
IgE concentrations were compared with those of the
Indian NEC group. Although the median total IgE levels
in the Indian NEC groups was higher than that of the
Gabonese EC group, suggesting that age could be an
important factor in IgE production, the higher IgE levels
in the Indian population may also be interpreted as the
result of either environmental factors, such as predomi-
nance of food allergies, of the genetic background, which
may predispose to developing IgE responses [13,27,29-
32] or of a co-infection with other parasites, such as
helminths affecting the IgE responses in these patients
[33,34]. In the Gabonese cohorts, IgE levels tended to cor-
relate negatively to parasitaemia except in UM whereas all
patient groups from India showed a positive correlation.
The pool of circulating IgE comprises both monomeric
and complexed immunoglobulins [35,36]. A functional
test was performed, based on the ability of the circulating
IgE from the sera of different patient groups to induce
degranulation of mast cells in the presence of pRBC anti-
gens to better estimate the P. falciparum specific IgE
response. This test does not provide specific IgE concen-
tration within total IgE. It is based on the specific IgE
induced percentage of mast cells degranulation. Degranu-
lation was measured by quantifying β-hexosaminidase
release. Functional P. falciparum-specific IgEs were
detected in randomly chosen patients from all groups in
both the Gabonese and Indian populations, except for
ExCM Indian patients. The highest percentage of patients
with functional anti-parasite IgEs was found in the
Gabonese AI and UM and Indian EC and UM groups,
which decreased in the SM and CM groups (Figure 3A and
3B). This suggests a protective role for P. falciparum-spe-
cific IgE, and is consistent with previous published data
[13,14].
Although the CM group had a low percentage of patients
able to induce degranulation, it was the only group where
there was one patient serum inducing a mast cell degran-
ulation above 30%. This intense response may be associ-
ated with the presence of IgE with higher affinity for P.
falciparum antigens, as previously reported by Gonzalez-
Espinosa et al. [37]. However, the level of degranulation
can also be enhanced by the number of receptors involved
in recognizing the antigen-IgE complex, which can
strongly affect the size of the secretory response [37,38].
There was no evident correlation between the level of
functional P. falciparum-specific IgE (percentage of
enzyme release) and the level of total IgE per group within
each population. This is unsurprising, given that both the
monomeric and complexed forms of circulating parasite-
specific IgE can affect the level of degranulation [39-41]. It
Table 4: Cytokine distribution in the Indian population: median TNF, IFN-γ and IL-10 per clinical group.
NEC (min-max) EC (min-max) UM (min-max) SM (min-max) CM (min-max) ExCM (min-
max)
TNF (pg/ml) 57 (39–73) 78 (63–120) 180 (119–207) 200 (173–381) 530 (258–1227) 81 (69–124)
IFN-γ (pg/ml) 23 (10–31) 22 (17–201) 119 (70–153) 127 (111–200) 65 (45–101) 32 (11–53)
IL-10 (pg/ml) 13 (5–26) 22 (11–31) 120 (97–147) 176 (121–253) 301 (175–506) 85 (40–108)
IL-4 (pg/ml) 18 (8–40) 58 (23–84) 65 (31–204) 69 (50–89) 62 (40–85) 48 (29–80)
NEC – non endemic control, EC – endemic control, UM – uncomplicated malaria, SM – severe malaria (non-cerebral), CM – cerebral malaria, 
ExCM – Ex-cerebral malaria.
Comparing group by group with the Endemic control: TNF was significantly lower in NEC (p = 0,0006) and higher in UM (p = 1,19 × 10-7), SM (p 
= 1,01 × 10-5) and CM (p = 2,26 × 10-7); IFN-γ was significantly higher in all diseased groups (UM – p = 5,11 × 10-6, SM – p = 1,01 × 10-6, CM – p 
= 9,71 × 10-6); IL-10 was significantly higher in all diseased groups (UM – p = 1,04 × 10-7, SM – p = 1,01 × 10-5 and CM – p = 2,46 × 10-7).Page 9 of 13
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Malaria Journal 2007, 6:1 http://www.malariajournal.com/content/6/1/1is also acceptable that total IgE levels were not directly cor-
related to FcåRI upregulation levels [40,42]. The mini-
mum level of receptors occupied by the parasite antigen-
specific IgE complex required to induce a degranulation
response is 10%. Consequently, this response will be
independent of the total IgE levels [20]. An increase in
specific IgE levels has been also seen in other parasitic
infections, such as helminthiasis, in which the specific
IgEs usually help to eliminate the pathogens either
through hypersensitivity reactions resulting from mast
cell degranulation or by inducing antibody-dependent
cell-mediated responses [27].
High levels of IgE in P. falciparum-infected individuals
have been shown to be due to an underlying imbalance in
favour of IL-4 in the ratio of CD4+ T cell producers, which
are responsible for the IgG/IgM isotype switching to IgE
[10]. High levels of circulating IL-4 have also been associ-
ated with a greater parasite antigen-specific production of
IgE in individuals less susceptible to malaria [13]. Also,
Th1-type pro-inflammatory cytokines, such as IFN-γ and
TNF are thought to play an important role in the both pro-
tecting against and increasing the pathogenesis of cerebral
malaria [3,4,22]. Plasma TNF, IFN-γ and IL-10 levels were
measured in both the Indian and Gabonese groups. In the
IL-10 correlation with total IgE levels in the Gabonese populationFigure 4
IL-10 correlation with total IgE levels in the Gabonese population. Dashed line - Asymptomatic patients (significant negative 
spearman correlation, p = 0.025). Bold line -  Uncomplicated malaria patients (significant positive correlation, p = 0.017).Page 10 of 13
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Malaria Journal 2007, 6:1 http://www.malariajournal.com/content/6/1/1Gabonese groups, no direct correlation was found
between IgE and IFN-γ or TNF levels in the UM, SM and
CM patients. However, the level of IgE production was
correlated to IL-10 levels in UM and AI patients (Figure 4).
In this group, there was a positive association between IL-
10 levels and parasite load, but not between IgE levels and
parasitaemia. In the Indian groups, IFN-γ, TNF and IL-10
levels were all significantly correlated with IgE levels inde-
pendent of the group (Figures 5A, B and 5C). When look-
ing for a correlation per group, no significant statistic
value was found. IL-4 is the main cytokine responsible for
IgE production, inducing antibody isotype switching from
IgG and IgM to IgE [10]. Previous studies have shown an
association between the IL-4/IFN-γ levels and IgE levels,
suggesting an induced Th2-type switched response [43].
As IL-4 levels were different between groups only in Indi-
ans, a correlation was expected between this ratio and IgE
levels, and surprisingly, the results showed an opposite
correlation (p = 0,012). The levels of IL-4 remained
almost constant across all groups as IgE levels increased.
Therefore, this opposite correlation arises due to a parallel
increase in both IFN-γ and IgE levels. This suggests that, in
the Indian population, IL-4 does not seem to directly
influence IgE levels. It has been shown experimentally
that there are conditions under which alternative mecha-
nisms may induce IgE production independent of IL-4
[44]. Regarding other cytokine ratios, like TNF/IL-10, no
significant correlation was found with total IgE levels.
Cytokine correlation with IgE levels in the Indian populationFigure 5
Cytokine correlation with IgE levels in the Indian population. A. TNF correlation with total IgE levels (significant positive spear-
man correlation, p = 0.0037); B. IFN-γ correlation with total IgE levels (Significant positive spearman correlation, p = 0.0028); 
C. IL-10 correlation with total IgE levels (significant positive spearman correlation, p = 0.0051).
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Malaria Journal 2007, 6:1 http://www.malariajournal.com/content/6/1/1In conclusion, these results showed that total IgE levels
increased in infected patients, mainly in UM and SM
patients but not in CM patients. The decrease in total IgE
levels in the CM group was associated with a higher inten-
sity of mast cell degranulation induced in vitro by P. falci-
parum-specific IgE. In addition, no correlation was found
between total and functional P. falciparum-specific IgE lev-
els.
The results reported here show the high activity of func-
tional circulating P. falciparum-specific IgE in asympto-
matic malaria patients. However, no correlation was
observed between plasma levels of total IgE, the disease
phenotype and the cytokines pattern in the different
groups of patients studied. The opposite association
between pro- and anti-inflammatory cytokine ratios and
IgE levels reveals the complexity of immune response dis-
ruption occurring during malaria in patients from low
and high malaria endemic region.
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